Wellspect HealthCare Launches Surity™ Female External Catheter Improving Care for Women Living with Severe Urinary Incontinence

Rhea-AI Summary

Wellspect HealthCare (XRAY) announced the U.S. launch of the Surity™ Female External Catheter, a non-invasive product intended to help women with severe urinary incontinence and their caregivers. The device is designed to prevent leakage, protect skin, and support extended overnight use while integrating with compatible urine collection systems.

The company said Surity™ addresses a gap in continence care for aging, neurologic, and mobility-limited populations. The female catheter is available for home purchase at www.surity.care, and a Surity™ urinary management system plus a male external catheter are planned for launch later in the year.

News Market Reaction – XRAY

-0.08%

1 alert

-0.08% News Effect

On the day this news was published, XRAY declined 0.08%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Americans affected: 13 million Company experience: 40+ years

2 metrics

Americans affected 13 million Severe urinary incontinence prevalence in the U.S.

Company experience 40+ years Wellspect HealthCare leadership in continence care innovation

Market Reality Check

Price: $12.71 Vol: Volume 3,940,618 is rough...

normal vol

$12.71 Last Close

Volume Volume 3,940,618 is roughly in line with the 20-day average of 4,023,342 (relative volume 0.98). normal

Technical Shares at 12.73 are trading below the 200-day MA of 13.61 and sit 38.19% under the 52-week high.

Peers on Argus

Key peers like NVST, LMAT, WRBY, ICUI, and MMSI all showed single-day declines b...

Key peers like NVST, LMAT, WRBY, ICUI, and MMSI all showed single-day declines between about -1% and -3%, indicating broader pressure in related medical instruments names even as XRAY traded lower on this product-launch news.

Historical Context

5 past events · Latest: Jan 14 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 14	Distribution partnership	Positive	+1.8%	Renewal of U.S. dental technology distribution agreement with Patterson Dental.
Jan 13	Expanded partnership	Positive	-3.0%	Expanded Benco Dental partnership to include full dental technology portfolio.
Jan 13	Board appointment	Neutral	-3.0%	Appointment of Donald Zurbay to Board and creation of growth committee.
Jan 12	Management hire	Neutral	-2.2%	Appointment of Mark R. Bezjak as Group VP, Americas commercial organization.
Jan 06	Conference appearance	Neutral	+0.0%	Planned presentation at the 44th J.P. Morgan Healthcare Conference.

Pattern Detected

Recent news has been generally strategic or partnership-focused, with mixed price reactions and several instances where positive corporate updates coincided with negative one-day moves.

Recent Company History

Over the past month, XRAY has issued multiple strategic announcements, including renewed and expanded U.S. distribution partnerships with Patterson Dental and Benco Dental, the appointment of Donald Zurbay to the Board and formation of a Growth and Value Creation Committee, and senior commercial leadership changes effective Jan 28, 2026. A presentation at the 44th J.P. Morgan Healthcare Conference highlighted its Connected Dentistry and return-to-growth strategy. Against this backdrop, today’s continence-care product launch reflects continued portfolio and channel development across adjacent healthcare areas.

Market Pulse Summary

This announcement highlights XRAY’s broader healthcare reach through Wellspect’s U.S. launch of the ...

Analysis

This announcement highlights XRAY’s broader healthcare reach through Wellspect’s U.S. launch of the Surity™ Female External Catheter for severe urinary incontinence, a condition affecting more than 13 million Americans. Recent history shows XRAY emphasizing partnerships, leadership changes, and strategic presentations around its return-to-growth plan. Investors may watch how this new category complements core dental technology, adoption trends in aging and mobility-limited populations, and future updates on commercialization progress.

Key Terms

female external catheter, urinary incontinence, continence care, urine collection systems

4 terms

female external catheter medical

"Surity™ Female External Catheter, a new non-invasive solution designed to support"

A female external catheter is a non-invasive device that fits against the outside of a woman’s body to collect urine without inserting anything into the bladder, functioning much like a soft adhesive cup or funnel. Investors care because these devices can reduce hospital stays, lower the risk of costly urinary infections, and create recurring sales and reimbursement opportunities in healthcare settings, making product adoption and regulatory approval key drivers of commercial performance.

urinary incontinence medical

"support women living with severe urinary incontinence."

Urinary incontinence is the involuntary leakage of urine when a person cannot fully control their bladder, ranging from occasional dribbles to frequent, heavy leakage. For investors, it matters because it creates a steady, measurable market for treatments, devices, surgeries and home-care services—similar to a leaky pipe that needs repair or regular management—which can drive sales, influence clinical trial and regulatory risk, and affect health-care spending and reimbursement decisions.

continence care medical

"a global provider of continence care solutions, today announced the U.S. launch"

Continence care is the range of products and services that help people manage loss of bladder or bowel control, including absorbent garments, skin-care items, monitoring devices and support services. Investors watch this sector because demand is steady and often grows with aging populations and long-term care needs, creating recurring revenue, predictable sales cycles and sensitivity to reimbursement rules and regulatory approvals—similar to investing in household essentials that people use daily.

urine collection systems medical

"suitable for use with compatible urine collection systems, Surity™ brings relevant"

Devices, containers and related tools used to collect, preserve and transport urine samples for medical tests, monitoring or treatment. Think of them as the reliable delivery containers and accessories that keep a lab sample intact from patient to laboratory; their design and quality affect test accuracy, infection control and regulatory approval. Investors watch them because demand, safety rules, and product innovation influence sales, recurring revenue and liability risk in healthcare and diagnostics markets.

AI-generated analysis. Not financial advice.

MÖLNDAL, Sweden, Jan. 26, 2026 /PRNewswire/ -- Wellspect HealthCare, a global provider of continence care solutions, today announced the U.S. launch of the innovative Surity™ Female External Catheter, a new non-invasive solution designed to support women living with severe urinary incontinence. Wellspect HealthCare has been a trusted healthcare leader and at the forefront of innovation for more than 40 years, with established product brands including LoFric^® and Navina™. Surity™ marks Wellspect's entry into a new category, bringing people suffering from severe urinary incontinence, and their caregivers, a reliable and comfortable urinary incontinence management solution.

Severe urinary incontinence is a defining challenge for more than 13 million Americansⁱ and their caregivers. Despite disruptions to sleep, falls, dehydration, skin breakdown, emotional distress and caregiver exhaustion,^{ii,iii,iv,v,vi,vii} there remain limited options for severe urinary incontinence management.^viii Whether providing care at home or in a healthcare setting, women, their caregivers and clinicians want to feel capable and have reliable tools that reduce strain, simplify routines, and support dignified care. Designed to be non-invasive, easy to place, and suitable for use with compatible urine collection systems, Surity™ brings relevant comfort to an area of care where few options exist.

"Severe urinary incontinence affects millions of women, many of whom live with multiple health conditions. The impact of severe urinary incontinence reaches far beyond the inconvenience of leaks, contributing to sleep loss, emotional distress and exhaustion for both patients and their caregivers," said Chris Schlenk, Group Vice President, Wellspect HealthCare. "As leaders in continence care, we're determined to support patients and caregivers by offering a reliable and accessible management option designed to restore comfort, rest and confidence to those who have lived with these silent struggles for too long."

Engineered to prevent leakage, protect skin, and support extended overnight use, Surity™ helps women and their caregivers confidently manage incontinence care through seamless integration into daily routines. The device is intended to make management of severe urinary incontinence more predictable, addressing a significant gap in continence care across aging, neurologic, and mobility-limited populations.

Wellspect will launch the advanced Surity™ Urinary Management System and male external catheter later this year. Surity™ Female External Catheter is now available for home purchase at www.surity.care and will soon be available to healthcare institutions.

To learn more about Surity™ please visit www.surity.care.

Pictures are available for download here
For more details, please contact:

Marion Par-Weixlberger | Vice President Public Relations, Corporate Communications & Brand
publicrelations@dentsplysirona.com

About Wellspect HealthCare
Wellspect HealthCare, a subsidiary of Dentsply Sirona, is a leading global provider of innovative medical devices dedicated to improving the quality of life for individuals with bladder and bowel dysfunction.
With approximately 1,200 employees worldwide, Wellspect is committed to making a real difference for people managing continence care needs, empowering them to live each day to the fullest.
Wellspect delivers solutions that support safe bladder and bowel management, and continuously enhances the user experience, clinical performance, and service quality for healthcare professionals and users alike.
As one of the world's leading manufacturers of intermittent urinary catheters, Wellspect has been at the forefront of innovation since 1983 with its LoFric^® brand, which introduced the first hydrophilic-coated catheter.
Wellspect has also pioneered the development of Navina™, an innovative transanal irrigation system designed to support individuals living with chronic bowel disorders.
Every day, Wellspect strives to maintain the highest quality standards while minimizing the environmental impact of its products.
Headquartered in Mölndal, Sweden, Wellspect operates in more than 40 countries, offering life-enhancing solutions to people around the world. Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, is listed on Nasdaq under the symbol XRAY.

LinkedIn: Wellspect HealthCare
Facebook: Wellspect
Instagram: Wellspect

ⁱLeslie SW, Tran LN, Puckett Y. Urinary Incontinence. [Updated 2024 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559095/
ⁱⁱDuncan I, Stocking A, Fitzner K, Ahmed T, Huynh N. The Prevalence of Incontinence and Its Association With Urinary Tract Infections, Dermatitis, Slips and Falls, and Behavioral Disturbances Among Older Adults in Medicare Fee-for-Service. J Wound Ostomy Continence Nurs. 2024 Mar-Apr 01;51(2):138-145. doi: 10.1097/WON.0000000000001054. PMID: 38527324; PMCID: PMC11008436.
ⁱⁱⁱAppeadu MK, Bordoni B. Falls and Fall Prevention in Older Adults. [Updated 2023 Jun 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560761/
^ivMayo Clinic Staff. "Bladder Control: Lifestyle Strategies Ease Problems." Mayo Clinic, May 10, 2025. https://www.mayoclinic.org/diseases-conditions/urinary-incontinence/in-depth/bladder-control-problem/art-20046597
^vNational Association for Continence. "The True Impact of Incontinence." NAFC (National Association for Continence), 2025. https://nafc.org/bhealth-blog/the-true-impact-of-incontinence/
^viCheng S, Lin D, Hu T, et al. Association of urinary incontinence and depression or anxiety: a meta-analysis. Journal of International Medical Research. 2020;48(6). doi:10.1177/0300060520931348
^viiFamily Caregiver Alliance. "Caring for Someone with Incontinence: Emotional and Social Issues." Family Caregiver Alliance, 2014. https://www.caregiver.org/resource/caring-someone-incontinence-emotional-and-social-issues/
^viiiBeeson T, Pittman J, Davis CR. Effectiveness of an External Urinary Device for Female Anatomy and Trends in Catheter-Associated Urinary Tract Infections. J Wound Ostomy Continence Nurs. 2023 Mar-Apr 01;50(2):137-141. doi: 10.1097/WON.0000000000000951. PMID: 36867037; PMCID: PMC9990593.

View original content to download multimedia:https://www.prnewswire.com/news-releases/wellspect-healthcare-launches-surity-female-external-catheter-improving-care-for-women-living-with-severe-urinary-incontinence-302669931.html

SOURCE Wellspect HealthCare

FAQ

When did Wellspect HealthCare (XRAY) launch the Surity™ Female External Catheter in the U.S.?

Wellspect HealthCare launched Surity™ Female External Catheter in the U.S. on January 26, 2026.

Where can patients and caregivers buy the Surity™ Female External Catheter for home use?

The Surity™ Female External Catheter is available for home purchase at www.surity.care.

Who is the Surity™ Female External Catheter intended to help and what settings is it for?

The device is intended for women living with severe urinary incontinence and their caregivers, for use at home and in healthcare settings with compatible urine collection systems.

What features does Wellspect cite for the Surity™ Female External Catheter?

Wellspect describes the device as non-invasive, easy to place, engineered to prevent leakage, protect skin, and support extended overnight use.

Will Wellspect introduce related Surity™ products beyond the female catheter in 2026?

Yes; the company plans to launch the Surity™ Urinary Management System and a male external catheter later in 2026.